GLENN JOHN 4

4 · IRADIMED CORP · Filed Jun 23, 2026

AI-generated summary of this filing

Updated Jun 23, 2026

IRADIMED (IRMD) CFO Glenn John Receives RSUs; 2,319 Shares Withheld

What Happened

Glenn John, Chief Financial Officer of Iradimed Corporation, had 5,796 restricted stock units (RSUs) convert into common shares on 2026-06-20.
Of those 5,796 shares, 2,319 were withheld to satisfy tax withholding at $92.20 per share (reported value $213,812). The net shares delivered to the insider were 3,477.
The full value of the vested 5,796 shares at $92.20 is roughly $534,391.

Key Details

Transaction date: 2026-06-20; filing date: 2026-06-23 (Form 4 accession 0001253497-26-000005).
Reported transaction codes: M = exercise/conversion of a derivative (RSU conversion to shares); F = payment of tax liability via share withholding.
Tax withholding: 2,319 shares withheld at $92.20/share for $213,812 (per filing).
Net shares received: 3,477 (5,796 vested − 2,319 withheld).
Shares owned after the transaction: not specified in the filing.
Footnotes: F1 notes each RSU equals one share on vesting; F2 states the RSUs were granted under the 2014 Equity Incentive Plan and vest in four equal annual installments beginning 6/30/2023.

Context

This was a routine RSU vesting and share-withholding for taxes (not an open-market sale). Withholding of shares to cover taxes is common and does not necessarily signal a buy or sell intent.
The filing shows conversion of RSUs (derivative) into shares and the related tax withholding, commonly called a cashless settlement/withholding.

Form 4

Period: 2026-06-20

CFO

Transactions

Exercise/Conversion
Common Stock
[F1]
2026-06-20+5,796→ 14,256 total
Tax Payment
Common Stock
2026-06-20$92.20/sh−2,319$213,812→ 11,937 total
Exercise/Conversion
Restricted Stock Units
[F1][F2]
2026-06-20−5,796→ 0 total
→ Common Stock (5,796 underlying)

Footnotes (2)

[F1]Each restricted stock unit represents a contingent right to receive one share of Iradimed Corporation's common stock.
[F2]The reporting person received restricted stock units under Iradimed Corporation's 2014 Equity Incentive Plan. The restricted stock units vest in four equal annual installments beginning on June 30, 2023. Upon vesting, the reporting person will receive a number of shares of common stock equal to the number of restricted stock units that have vested.

Signature

/s/ John Glenn|2026-06-23

1 file